Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Concurrent Chemoradiotherapy”

716 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 716 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06540950
What this trial is testing

Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer

Who this might be right for
Vinorelbine
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 47
Testing effectiveness (Phase 2)UnknownNCT05512520
What this trial is testing

Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma（EC-CRT-003）

Who this might be right for
Metastatic Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 126
Large-scale testing (Phase 3)Study completedNCT03957590
What this trial is testing

Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
BeiGene 370
Not applicableUnknownNCT04171986
What this trial is testing

Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis

Who this might be right for
Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 93
Early research (Phase 1)UnknownNCT04522050
What this trial is testing

Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University 65
Large-scale testing (Phase 3)Study completedNCT00201396
What this trial is testing

Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
National Health Research Institutes, Taiwan 480
Large-scale testing (Phase 3)Ended earlyNCT04866017
What this trial is testing

Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
BeiGene 63
Not applicableLooking for participantsNCT07585929
What this trial is testing

Stereotactic Body Radiotherapy Boost Versus Simultaneous Integrated Boost to Pelvic Nodes Among Patients Receiving Radical Chemoradiation in Carcinoma Cervix

Who this might be right for
Stage IIIC
All India Institute of Medical Sciences 150
Testing effectiveness (Phase 2)Study completedNCT02776137
What this trial is testing

Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Head-and-neck CancerSquamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 91
Large-scale testing (Phase 3)UnknownNCT01755845
What this trial is testing

Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer Patients

Who this might be right for
Cervical Cancer
xie congying 300
Large-scale testing (Phase 3)Looking for participantsNCT04376866
What this trial is testing

Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Cancer Hospital of Guangxi Medical University 204
Testing effectiveness (Phase 2)UnknownNCT05311566
What this trial is testing

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Who this might be right for
Cervical CarcinomaChemoradiotherapyAnti-programmed Cell Death Receptor 1+6 more
Lei Li 92
Large-scale testing (Phase 3)UnknownNCT01854203
What this trial is testing

Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 300
Not applicableActive Not RecruitingNCT03979924
What this trial is testing

Mouth Opening, Prevention, Education, Nutrition (OPEN)

Who this might be right for
TrismusHead and Neck Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 175
Testing effectiveness (Phase 2)Ended earlyNCT00271323
What this trial is testing

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Who this might be right for
Non-Small-Cell Lung Carcinoma
Sanofi 14
Large-scale testing (Phase 3)Looking for participantsNCT05527470
What this trial is testing

Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 440
Testing effectiveness (Phase 2)Active Not RecruitingNCT03389477
What this trial is testing

Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine 26
Large-scale testing (Phase 3)Looking for participantsNCT06992609
What this trial is testing

Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.

Who this might be right for
Small Cell Lung Carcinoma
AstraZeneca 70
Testing effectiveness (Phase 2)Looking for participantsNCT03694236
What this trial is testing

Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLC

Who this might be right for
Potentially Resectable Stage II/IIIa NSCLC
Yonsei University 39
Not applicableActive Not RecruitingNCT04874493
What this trial is testing

Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Carcinoma
M.D. Anderson Cancer Center 77
Load More Results